Tröster Alexander I
Department of Clinical Neuropsychology and Center for Neuromodulation, Barrow Neurological Institute, Phoenix, AZ, USA.
Arch Clin Neuropsychol. 2017 Nov 1;32(7):810-828. doi: 10.1093/arclin/acx090.
Deep brain stimulation (DBS) is an effective (but non-curative) treatment for some of the motor symptoms and treatment complications associated with dopaminergic agents in Parkinson's disease (PD). DBS can be done relatively safely and is associated with quality of life gains. In most DBS centers, neuropsychological evaluations are performed routinely before surgery, and sometimes after surgery. The purpose of such evaluation is not to decide solely on its results whether or not to offer DBS to a given candidate, but to provide the patient and treatment team with the best available information to make reasonable risk-benefit assessments. This review provides information relevant to the questions often asked by patients and their carepartners, neurologists, and neurosurgeons about neuropsychological outcomes of DBS, including neuropsychological adverse event rates, magnitude of cognitive changes, outcomes after unilateral versus bilateral surgery directed at various targets, impact of mild cognitive impairment (MCI) on outcome, factors implicated in neurobehavioral outcomes, and safety of newer interventions or techniques such as asleep surgery and current steering.
深部脑刺激(DBS)是治疗帕金森病(PD)中一些与多巴胺能药物相关的运动症状及治疗并发症的一种有效(但非治愈性)方法。DBS实施起来相对安全,且与生活质量改善相关。在大多数DBS中心,术前通常会进行神经心理学评估,有时术后也会进行。此类评估的目的并非仅依据其结果来决定是否为特定候选人提供DBS,而是为患者和治疗团队提供最佳可用信息,以便进行合理的风险效益评估。本综述提供了与患者及其护理伙伴、神经科医生和神经外科医生经常问到的关于DBS神经心理学结果的问题相关的信息,包括神经心理学不良事件发生率、认知变化程度、针对不同靶点的单侧与双侧手术后的结果、轻度认知障碍(MCI)对结果的影响、与神经行为结果相关的因素,以及诸如睡眠中手术和电流导向等新干预措施或技术的安全性。